What GENZYME CORP's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sanofi | 10% owner | Apr 08 | Open-market buy · P | +16,245,894 | $76.33 | +$1.24B | 253,558,720 |
| Sanofi | 10% owner | Apr 08 | Open-market buy · P | +4,435,393 | — | — | 237,312,826 |
| Sanofi | 10% owner | Apr 07 | Open-market buy · P | +44,891,208 | — | — | 232,877,433 |
| Sanofi | 10% owner | Apr 06 | Open-market buy · P | +3,947,680 | — | — | 187,986,225 |
| Geraghty James A | Senior Vice President | Apr 04 | Tender Offer · U | −112 | $74.00 | −$8.29K | 0 |
| Geraghty James A | Senior Vice President | Apr 04 | Disposition to Issuer · D | −9,750 | $74.00 | −$722K | 0 |
| Geraghty James A | Senior Vice President | Apr 04 | Tender Offer · U | −4,845 | $74.00 | −$359K | 9,750 |
| Geraghty James A | Senior Vice President | Apr 04 | Exercise / conversion · M | +4,750 | — | — | 14,595 |
| Geraghty James A | Senior Vice President | Apr 04 | Exercise / conversion · M | +5,000 | — | — | 9,845 |
| DesRosier Thomas | Sr VP, General Counsel | Apr 04 | Tender Offer · U | −779 | $74.00 | −$57.6K | 0 |
| DesRosier Thomas | Sr VP, General Counsel | Apr 04 | Tender Offer · U | −779 | $74.00 | −$57.6K | 0 |
| DesRosier Thomas | Sr VP, General Counsel | Apr 04 | Tender Offer · U | −4,947 | $74.00 | −$366K | 0 |
| DesRosier Thomas | Sr VP, General Counsel | Apr 04 | Disposition to Issuer · D | −11,375 | $74.00 | −$842K | 0 |
| DesRosier Thomas | Sr VP, General Counsel | Apr 04 | Tender Offer · U | −5,738 | $74.00 | −$425K | 11,375 |
| DesRosier Thomas | Sr VP, General Counsel | Apr 04 | Exercise / conversion · M | +5,542 | — | — | 17,113 |
| DesRosier Thomas | Sr VP, General Counsel | Apr 04 | Exercise / conversion · M | +5,833 | — | — | 11,571 |
| Meeker David P | ExecVP,Chief Operating Officer | Apr 04 | Tender Offer · U | −621 | $74.00 | −$46K | 0 |
| Meeker David P | ExecVP,Chief Operating Officer | Apr 04 | Tender Offer · U | −120 | $74.00 | −$8.88K | 0 |
| Meeker David P | ExecVP,Chief Operating Officer | Apr 04 | Tender Offer · U | −375 | $74.00 | −$27.8K | 0 |
| Meeker David P | ExecVP,Chief Operating Officer | Apr 04 | Tender Offer · U | −210 | $74.00 | −$15.5K | 0 |
Loading...
